News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Evotec AG Reports Strong Third Quarter 2008 and Improves Full-Year Guidance
November 14, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
HAMBURG, Germany, Nov. 14, 2008 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) today reported results for the third quarter and nine months ended September 30, 2008.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Manufacturing
Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars
August 18, 2026
·
2 min read
·
Nick Paul Taylor
Dermatology
LEO adds to dermatology portfolio with $435M deal for late-stage rare disease drug
August 18, 2026
·
1 min read
·
Annalee Armstrong
Manufacturing
Rebounding biotech funds expected to spur CDMO growth within year
August 18, 2026
·
2 min read
·
Nick Paul Taylor
Drug Development
EyePoint’s Phase 3 fail sends stock spiraling amid next-gen AMD race
August 17, 2026
·
3 min read
·
Gabrielle Masson
